http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling. A countrywide study in Germany deemed PRRT treatment not only safe and effective but life-prolonging, according to a study unveiled during the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting. http://medicalxpress.com/news/2013-06-radiopeptide-therapy-survival-outcomes-neuroendocrine.html Cancer Tue, 11 Jun 2013 09:13:42 EST news290160814 (Medical Xpress)—Doctors at Washington University School of Medicine in St. Louis have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients will do well or poorly with standard treatment. The study supports the future possibility of personalized medicine for cervical cancer, a tumor normally addressed with a one-size-fits-all approach. http://medicalxpress.com/news/2013-05-pretesting-cervical-tumors-treatment.html Cancer Fri, 31 May 2013 08:10:01 EST news289203862 Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology. http://medicalxpress.com/news/2013-05-older-prostate-cancer-patients-treatment.html Cancer Mon, 20 May 2013 17:44:42 EST news288290675 Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days—a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. http://medicalxpress.com/news/2013-05-breast-cancer-treatment-varies-patient-doctor.html Cancer Tue, 07 May 2013 12:37:05 EST news287149018 Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, according to a newly published study from Henry Ford Hospital in Detroit. http://medicalxpress.com/news/2013-03-hpv-survival-african-americans-throat-cancer.html Cancer Thu, 28 Mar 2013 12:22:32 EST news283692087 Patients with locally advanced cervical cancer have better treatment outcomes and are more likely to survive the disease if they receive care at a high-volume medical center than patients treated at low-volume facilities, according to research presented today at the Society of Gynecologic Oncology's annual meeting on women's cancers in Los Angeles. http://medicalxpress.com/news/2013-03-cervical-cancer-patients-survive-high-volume.html Cancer Tue, 12 Mar 2013 10:00:01 EST news282300062 Patients who received an implantable heart defibrillator in everyday practice had survival benefits on par with those who received the same devices in carefully controlled clinical trials, according to a new study that highlights the value of defibrillators in typical medical settings. http://medicalxpress.com/news/2013-01-real-world-patient-survival-defibrillators-trial.html Cardiology Tue, 01 Jan 2013 16:08:57 EST news276278921 Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and distinguish clinically-relevant cancers. http://medicalxpress.com/news/2012-12-game-diagnostic-prognostic-prostate-cancer.html Cancer Thu, 20 Dec 2012 12:15:38 EST news275228128 Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not get cured with current standard treatments such as chemotherapy and stem cell transplantation, with an average survival of only about four years. FAIM could thus be a therapeutic target in these patients, as drugs developed to target the molecule could destroy multiple myeloma cells and hence eradicate the cancer. http://medicalxpress.com/news/2012-12-scientists-biomarker-cancer-bone-marrow.html Cancer Thu, 13 Dec 2012 08:25:56 EST news274609544 (HealthDay)—People whose hearts stop abruptly are only half as likely to be given bystander-initiated CPR in poor black neighborhoods as they are in higher-income white areas, a new study indicates. http://medicalxpress.com/news/2012-10-bystander-cpr-poor-black-neighborhoods.html Other Wed, 24 Oct 2012 17:40:07 EST news270317473 Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in BioMed Central's open access journal Breast Cancer Research shows that women whose HER2 positive cancer was also hormone (estrogen and progesterone) receptor (HR) negative had an increased risk of early death, and that their cancer was less likely to recur in bone than those whose cancer retained hormone sensitivity. http://medicalxpress.com/news/2012-10-breast-cancer-recurrence-hormone-receptor.html Cancer Mon, 01 Oct 2012 02:26:55 EST news268277209 (Medical Xpress)—Scientists at The University of Nottingham have identified a protein which could help predict survival outcomes for women with the most aggressive forms of breast cancer. http://medicalxpress.com/news/2012-09-thousands-women-aggressive-breast-cancer.html Cancer Fri, 07 Sep 2012 06:44:56 EST news266219086 (HealthDay)—Accelerated partial breast irradiation (APBI) yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation (WBI), with excellent three-year survival for women who develop an ipsilateral breast tumor recurrence (IBTR), according to a study published in the Sept. 1 issue of Cancer. http://medicalxpress.com/news/2012-08-outcomes-similar-partial-breast-irradiation.html Cancer Fri, 24 Aug 2012 14:10:01 EST news265033685 Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers. http://medicalxpress.com/news/2012-07-hpv-survival-african-americans-throat-cancer.html Cancer Thu, 19 Jul 2012 12:43:39 EST news261920609 The development of a highly accurate, blood-based pancreatic adenocarcinoma screen that would be accurate enough to test the general population for this deadly disease may not be far out of reach, according to data presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, held here June 18-21, 2012. http://medicalxpress.com/news/2012-06-biomarker-panel-screen-pancreatic-cancer.html Cancer Tue, 19 Jun 2012 15:30:15 EST news259332637 Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone. http://medicalxpress.com/news/2012-06-chemotherapy-effective-patients-resected-sclc.html Cancer Fri, 15 Jun 2012 18:55:46 EST news259005096 Scientists have long believed that vitamin D, which is naturally absorbed from sunlight, has an important role in the functioning of the body's autoimmune system. Now Prof. Howard Amital of Tel Aviv University's Sackler Faculty of Medicine and Sheba Medical Center has discovered that the vitamin may also affect the outcomes of patients in intensive care. http://medicalxpress.com/news/2012-04-ray-sunshine-critically-ill.html Health Tue, 03 Apr 2012 11:16:14 EST news252670560 New research published online in the FASEB Journal details a new antibody, called "OPN-305" that may significantly improve survival outcomes for those receiving donated kidneys and other organs. OPN-305 works by preventing inflammation triggered by oxygen deprivation in the donated organ, allowing for better recovery after transplantation. Specifically, it binds to sensors on transplant tissue, called "toll-like receptors" or "TLR-2," in the circulating blood and turns off signals that provoke inflammation. In addition, the compound is likely to extend the life of a donated organ after it has been transplanted. http://medicalxpress.com/news/2012-01-agent-kidney-transplant-survival-mice.html Other Tue, 31 Jan 2012 10:26:33 EST news247227984 An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States. http://medicalxpress.com/news/2012-01-drug-survival-colorectal-cancer-patients.html Cancer Wed, 18 Jan 2012 03:47:37 EST news246080849 Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. http://medicalxpress.com/news/2011-12-obesity-linked-worse-outcomes-early.html Cancer Thu, 08 Dec 2011 04:40:02 EST news242539870 The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease recurrence among postmenopausal women with early hormone receptor-positive breast cancer, according to new data from the ZO-FAST trial. http://medicalxpress.com/news/2011-12-bisphosphonate-endocrine-therapy-survival-postmenopausal.html Cancer Wed, 07 Dec 2011 12:15:13 EST news242482471 African-American patients with resected stage II and stage III colon cancer experienced worse overall and recurrence-free survival compared to whites, but similar recurrence-free intervals, according to a study published Oct. 12 in the Journal of the National Cancer Institute. http://medicalxpress.com/news/2011-10-survival-disparities-african-american-white-colo-rectal.html Cancer Wed, 12 Oct 2011 16:40:44 EST news237656433 New research shows liver transplantation candidates without hepatocellular carcinoma (HCC) derive a greater survival benefit from a living donor liver transplant (LDLT) than waiting for a deceased donor liver transplant (DDLT). The study now available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, reports that survival benefit from LDLT remains significant across the range of model for end-stage liver disease (MELD) scores, but this benefit was not apparent for low MELD candidates with HCC. http://medicalxpress.com/news/2011-09-donor-liver-transplantation-survival-deceased.html Other Tue, 27 Sep 2011 10:02:56 EST news236336564 A new study shows that removing lymph nodes due to the presence of occult, or microscopic, cancer cells found in the sentinel lymph node – the one closest to the tumor -- has no impact on survival outcomes of women with early-stage breast cancer. The principal investigator of the study is Armando E. Giuliano, MD, of Cedars-Sinai, who already is renowned for his clinical expertise and for his seminal research on lymph node removal in women with early-stage breast cancer. http://medicalxpress.com/news/2011-07-hidden-cancer-cells-factor-early-stage.html Cancer Tue, 26 Jul 2011 16:00:31 EST news230886044